rs761991070
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PP3_ModeratePP5_ModerateBS2
The NM_002461.3(MVD):āc.746T>Cā(p.Phe249Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000218 in 1,602,610 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (ā ).
Frequency
Genomes: š 0.000020 ( 0 hom., cov: 34)
Exomes š: 0.000022 ( 0 hom. )
Consequence
MVD
NM_002461.3 missense
NM_002461.3 missense
Scores
8
10
1
Clinical Significance
Conservation
PhyloP100: 6.65
Genes affected
MVD (HGNC:7529): (mevalonate diphosphate decarboxylase) The enzyme mevalonate pyrophosphate decarboxylase catalyzes the conversion of mevalonate pyrophosphate into isopentenyl pyrophosphate in one of the early steps in cholesterol biosynthesis. It decarboxylates and dehydrates its substrate while hydrolyzing ATP. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.93
PP5
Variant 16-88655350-A-G is Pathogenic according to our data. Variant chr16-88655350-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 253039.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAdExome4 at 32 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MVD | NM_002461.3 | c.746T>C | p.Phe249Ser | missense_variant | 7/10 | ENST00000301012.8 | NP_002452.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MVD | ENST00000301012.8 | c.746T>C | p.Phe249Ser | missense_variant | 7/10 | 1 | NM_002461.3 | ENSP00000301012.3 | ||
MVD | ENST00000565149.5 | n.1305T>C | non_coding_transcript_exon_variant | 3/6 | 1 | |||||
MVD | ENST00000569177.5 | c.*35T>C | downstream_gene_variant | 5 | ENSP00000455131.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152212Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
3
AN:
152212
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000482 AC: 11AN: 227992Hom.: 0 AF XY: 0.0000405 AC XY: 5AN XY: 123532
GnomAD3 exomes
AF:
AC:
11
AN:
227992
Hom.:
AF XY:
AC XY:
5
AN XY:
123532
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000221 AC: 32AN: 1450398Hom.: 0 Cov.: 32 AF XY: 0.0000222 AC XY: 16AN XY: 720478
GnomAD4 exome
AF:
AC:
32
AN:
1450398
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
720478
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152212Hom.: 0 Cov.: 34 AF XY: 0.0000269 AC XY: 2AN XY: 74360
GnomAD4 genome
AF:
AC:
3
AN:
152212
Hom.:
Cov.:
34
AF XY:
AC XY:
2
AN XY:
74360
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
8
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Porokeratosis 7, multiple types Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Oct 09, 2024 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is likely a mechanism of disease in this gene and is associated with porokeratosis 7, multiple types (MIM#614714). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0112 - The condition associated with this gene has incomplete penetrance. Variable penetrance has been described as it is suspected to cause disease only when a somatic second hit occurs (PMID: 38283795) . (I) 0115 - Variants in this gene are known to have variable expressivity. Individuals in the same family carrying the same pathogenic variant showed different clinical manifestations and severity (PMID: 26202976). (I) 0200 - Variant is predicted to result in a missense amino acid change from phenylalanine to serine. (I) 0251 - This variant is heterozygous. (I) 0302 - Variant is present in gnomAD (v2) <0.001 for a dominant condition (13 heterozygotes, 0 homozygotes). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v2) (1 heterozygotes, 0 homozygotes). (I) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated mevalonate 5-diphosphate decarboxylase C-terminal domain (DECIPHER). (I) 0705 - No comparable missense variants have previous evidence for pathogenicity. (I) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported as pathogenic in many individuals with porokeratosis, including both familial cases and sporadic cases (PMIDs: 26202976, 27422687, 29722423, 38283795). (SP) 0901 - This variant has strong evidence for segregation with disease. This variant has been shown to segregate with disease in a large family (PMID: 26202976). (SP) 1206 - This variant has been shown to be paternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 23, 2015 | - - |
MVD-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 23, 2024 | The MVD c.746T>C variant is predicted to result in the amino acid substitution p.Phe249Ser. This variant has been reported in multiple individuals with porokeratosis (Shi et al. 2020. PubMed ID: 33168400; Shiiya et al. 2021. PubMed ID: 33481264; Wang et al. 2024. PubMed ID: 38283795). Moreover, this variant has been observed to co-segregate with disease in a large family with porokeratosis (Zhang et al. 2015. PubMed ID: 26202976). This variant is reported in 0.069% of alleles in individuals of East Asian descent in gnomAD. This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
H
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Uncertain
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MutPred
Gain of disorder (P = 0.0039);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at